Literature DB >> 19394992

Ultrasound triggered cell death in vitro with doxorubicin loaded poly lactic-acid contrast agents.

J R Eisenbrey1, P Huang, J Hsu, M A Wheatley.   

Abstract

Traditional chemotherapy generally results in systemic toxicity, which also limits drug levels at the area of need. Two ultrasound contrast agents (UCA), with diameters between 1-2 microm in diameter and shell thicknesses of 100-200 nm, composed of poly lactic-acid (PLA), one loaded by surface adsorption and the other loaded by drug incorporation in the shell, were compared in vitro for potential use in cancer therapy. These poly lactic-acid (PLA) UCA platforms contain a gas core that in an ultrasound (US) field can cause the UCA to oscillate or rupture. Following a systemic injection of drug loaded UCA with external application of US focused at the area of interest, this platform could potentially increase drug toxicity at the area of need, while protecting healthy tissue through microencapsulation of the drug. In vitro toxicity in MDA-MB-231 breast cancer cells of the surface-adsorbed and shell-incorporated doxorubicin (Dox) loaded UCA were examined at 5 MHz insonation using a pulse repetition frequency of 100 Hz at varying pressure amplitudes. Both platforms resulted in equivalent cell death compared to free Dox and US when insonated at peak positive pressure amplitudes of 1.26 MPa and above. While no significant changes in cell death were seen for surface adsorbed Dox-UCA with or without insonation, cell death using the platform with Dox incorporated within the shell increased from 16.12% to 25.78% (p=0.0272), approaching double the potency of the platform when insonated at peak positive pressure amplitudes of 1.26 MPa and above. This mechanism is believed to be the result of UCA rupture at higher insonation pressure amplitudes, resulting in more exposed drug and shell surface area as well as increased cellular uptake of Dox containing polymer shell fragments. This study has shown that a polymer UCA with drug housed within the shell may be used for US-triggered cell death. US activation can be used to make a carrier significantly more potent once in the area of need.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394992      PMCID: PMC2783845          DOI: 10.1016/j.ultras.2009.03.003

Source DB:  PubMed          Journal:  Ultrasonics        ISSN: 0041-624X            Impact factor:   2.890


  17 in total

Review 1.  Therapeutic use of ultrasound targeted microbubble destruction: a review of non-cardiac applications.

Authors:  R Bekeredjian; H A Katus; H F Kuecherer
Journal:  Ultraschall Med       Date:  2006-04       Impact factor: 6.548

2.  Effect of ultrasound-activated microbubbles on the cell electrophysiological properties.

Authors:  T A Tran; S Roger; J Y Le Guennec; F Tranquart; A Bouakaz
Journal:  Ultrasound Med Biol       Date:  2007-01       Impact factor: 2.998

3.  Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent.

Authors:  Margaret A Wheatley; Flemming Forsberg; Kelleny Oum; Raymond Ro; Dalia El-Sherif
Journal:  Ultrasonics       Date:  2006-05-08       Impact factor: 2.890

4.  Sonoporation from jetting cavitation bubbles.

Authors:  Claus-Dieter Ohl; Manish Arora; Roy Ikink; Nico de Jong; Michel Versluis; Michael Delius; Detlef Lohse
Journal:  Biophys J       Date:  2006-09-01       Impact factor: 4.033

5.  Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation.

Authors:  Annemieke van Wamel; Klazina Kooiman; Miranda Harteveld; Marcia Emmer; Folkert J ten Cate; Michel Versluis; Nico de Jong
Journal:  J Control Release       Date:  2006-03-06       Impact factor: 9.776

Review 6.  Ultrasound, cavitation bubbles and their interaction with cells.

Authors:  Junru Wu; Wesley L Nyborg
Journal:  Adv Drug Deliv Rev       Date:  2008-04-08       Impact factor: 15.470

7.  Ultrasound enhances gene delivery of human factor IX plasmid.

Authors:  Carol H Miao; Andrew A Brayman; Keith R Loeb; Peiqing Ye; Ling Zhou; Pierre Mourad; Lawrence A Crum
Journal:  Hum Gene Ther       Date:  2005-07       Impact factor: 5.695

8.  Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography.

Authors:  Julie A Straub; Donald E Chickering; Charles C Church; Bhavdeep Shah; Thomas Hanlon; Howard Bernstein
Journal:  J Control Release       Date:  2005-08-29       Impact factor: 9.776

9.  Oil-filled polymer microcapsules for ultrasound-mediated delivery of lipophilic drugs.

Authors:  Klazina Kooiman; Marcel R Böhmer; Marcia Emmer; Hendrik J Vos; Ceciel Chlon; William T Shi; Christopher S Hall; Suzanne H P M de Winter; Karin Schroën; Michel Versluis; Nico de Jong; Annemieke van Wamel
Journal:  J Control Release       Date:  2008-10-09       Impact factor: 9.776

10.  Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent.

Authors:  E C Unger; T P McCreery; R H Sweitzer; V E Caldwell; Y Wu
Journal:  Invest Radiol       Date:  1998-12       Impact factor: 6.016

View more
  11 in total

1.  Breast Cancer Brain Metastasis Response to Radiation After Microbubble Oxygen Delivery in a Murine Model.

Authors:  Lauren J Delaney; Lorela Ciraku; Brian E Oeffinger; Corinne E Wessner; Ji-Bin Liu; Jingzhi Li; Kibo Nam; Flemming Forsberg; Dennis B Leeper; Patrick O'Kane; Margaret A Wheatley; Mauricio J Reginato; John R Eisenbrey
Journal:  J Ultrasound Med       Date:  2019-05-23       Impact factor: 2.153

2.  Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.

Authors:  Michael C Cochran; John Eisenbrey; Richard O Ouma; Michael Soulen; Margaret A Wheatley
Journal:  Int J Pharm       Date:  2011-05-13       Impact factor: 5.875

3.  Development of an ultrasound sensitive oxygen carrier for oxygen delivery to hypoxic tissue.

Authors:  John R Eisenbrey; Lorenzo Albala; Michael R Kramer; Nick Daroshefski; David Brown; Ji-Bin Liu; Maria Stanczak; Patrick O'Kane; Flemming Forsberg; Margaret A Wheatley
Journal:  Int J Pharm       Date:  2014-11-18       Impact factor: 5.875

4.  Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model.

Authors:  Michael C Cochran; John R Eisenbrey; Michael C Soulen; Susan M Schultz; Richard O Ouma; Sarah B White; Emma E Furth; Margaret A Wheatley
Journal:  Acad Radiol       Date:  2011-11       Impact factor: 3.173

5.  In vitro ultrasound experiments: Standing wave and multiple reflections influence on the outcome.

Authors:  Wojciech Secomski; Krzysztof Bilmin; Tamara Kujawska; Andrzej Nowicki; Paweł Grieb; Peter A Lewin
Journal:  Ultrasonics       Date:  2017-02-20       Impact factor: 2.890

6.  Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion.

Authors:  Mario L Fabiilli; Kevin J Haworth; Ian E Sebastian; Oliver D Kripfgans; Paul L Carson; J Brian Fowlkes
Journal:  Ultrasound Med Biol       Date:  2010-08       Impact factor: 2.998

7.  Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery.

Authors:  J R Eisenbrey; O Mualem Burstein; R Kambhampati; F Forsberg; J-B Liu; M A Wheatley
Journal:  J Control Release       Date:  2010-01-06       Impact factor: 9.776

8.  Determination of the interfacial rheological properties of a poly(DL-lactic acid)-encapsulated contrast agent using in vitro attenuation and scattering.

Authors:  Shirshendu Paul; Daniel Russakow; Tyler Rodgers; Kausik Sarkar; Michael Cochran; Margaret A Wheatley
Journal:  Ultrasound Med Biol       Date:  2013-05-01       Impact factor: 2.998

9.  Gemcitabine-loaded microbubble system for ultrasound imaging and therapy.

Authors:  Lauren J Delaney; John R Eisenbrey; David Brown; Jonathan R Brody; Masaya Jimbo; Brian E Oeffinger; Maria Stanczak; Flemming Forsberg; Ji-Bin Liu; Margaret A Wheatley
Journal:  Acta Biomater       Date:  2021-05-31       Impact factor: 10.633

10.  Lung surfactant microbubbles increase lipophilic drug payload for ultrasound-targeted delivery.

Authors:  Shashank R Sirsi; Chinpong Fung; Sumit Garg; Mary Y Tianning; Paul A Mountford; Mark A Borden
Journal:  Theranostics       Date:  2013-05-20       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.